Project
SAKK 08/15 PROMET
Ongoing - recruitment closed · 2017 until 2030
Putora Paul Martin, Panje Cédric
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Ongoing - recruitment closed
Start Date
2017
End Date
2030
Financing
SAKK
Study Design
International multicenter, randomized phase II trial.
Brief description/objective
PROMET - Multicenter, Randomized Phase II Trial of Salvage Radiotherapy +/- Metformin for Patients with Prostate Cancer after Prostatectomy
The main objective of the trial is to explore the efficacy of SRT plus metformin compared to SRT in the endpoint of time to progression after prostatectomy failure.